Venus Remedies gets marketing approval from 4 countries for chemotherapy drugs

05 Jul 2023 Evaluate

Venus Remedies has received marketing approval from Oman, Malaysia, Bosnia and Trinidad and Tobago for key chemotherapy drugs. With this, it has secured 503 marketing approvals for its oncology products across 75 countries. 

These marketing approvals will enable it to expand its operations to new geographies and open up new avenues for advanced cancer treatment with improved outcomes for patients battling various types of cancer.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers. 

Venus Remedies Share Price

736.00 14.60 (2.02%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×